Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > OMP > 2017 > OmW3D > OmW3D.1

Phase 1 clinical experience with BLZ-100 for near-infrared fluorescence guided tumor resection

Julie Novak

Open Access Open Access

Abstract

BLZ-100 is an optical contrast agent composed of chlorotoxin and indocyanine green. Clinical trials in multiple tumor types enabled tandem evaluation of BLZ-100 with clinical imaging devices. Safety and imaging data support further clinical development.

© 2017 Optical Society of America

PDF Article
More Like This
Interventional fluorescence spectroscopy: preliminary results to detect tumor margins during glioma resection with two fluorescence spectra of PpIX

L.M. Alston, J. Guyotat, L. Mahieu-Williame, M. Hebert, P. Kantapareddy, D. Meyronet, D. Rousseau, and B. Montcel
104110C European Conference on Biomedical Optics (ECBO) 2017

Near Infrared Active Nanomaterials for the Theragnosis of Tumors In Vivo

Tzu-Ming Liu
5p_A409_6 JSAP-OSA Joint Symposia (JSAP) 2017

Pharmacokinetics of ICG and HPPH-car for Detection of Normal and Tumor Tissue Using Fluorescence, Near-Infrared Continuous Wave Imaging

Michael Gurfinkel, Alan B. Thompson, William Ralston, Tamara L. Troy, Jeffery S. Reynolds, Bruce Muggenberger, Kristin Nikula, Ravindra Pandey, Ralf Mayer, Daniel J. Hawrysz, and Eva M. Sevick-Muraca
MD7 Biomedical Optical Spectroscopy and Diagnostics (BIOMED) 2000

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use